Evergreen Therapeutics
Evergreen Therapeutics is an AI-driven international innovative pharmaceutical company founded in 2019, focusing on clinical drug development with a strong emphasis on addressing urgent clinical needs. The company operates in major markets including China and the USA, leveraging its proprietary AI platform for clinical design and research. With a dual business model, Evergreen develops its own innovative drugs in ophthalmology, vascular, and immune-related fields while also providing high-end customized services to other pharmaceutical companies. Currently, half of its ten proprietary drug pipelines are in advanced clinical stages, supported by over 50 patent applications, positioning the company as a leader in AI-driven drug innovation.
Evergreen Therapeutics
Evergreen Therapeutics is an AI-driven international innovative pharmaceutical company founded in 2019, focusing on clinical drug development with a strong emphasis on addressing urgent clinical needs. The company operates in major markets including China and the USA, leveraging its proprietary AI platform for clinical design and research. With a dual business model, Evergreen develops its own innovative drugs in ophthalmology, vascular, and immune-related fields while also providing high-end customized services to other pharmaceutical companies. Currently, half of its ten proprietary drug pipelines are in advanced clinical stages, supported by over 50 patent applications, positioning the company as a leader in AI-driven drug innovation.